A selection of essential articles read aloud from the latest issue of The Economist. This week, the role of big government in the time of covid-19, (10:20) assessing the havoc the pandemic is causing in emerging countries, (17:45).
In just a few weeks a virus a ten-thousandth of a millimetre in diameter has transformed Western democracies. States have shut down businesses and sealed people indoors. They have promised trillions of dollars to keep the economy on life support. If South Korea and Singapore are a guide, medical and electronic privacy are about to be cast aside. It is the most dramatic extension of state power since the second world war.
Monocle 24’s Tyler Brûlé is joined by Benno Zogg and Juliet Linley for a look at how the global press is covering the pandemic and whether the tone of the discussion needs a rethink. Plus: Andrew Mueller’s look at what we learnt this week.
When he was interviewed, the count of Covid-19 cases stood at 412, less than 12 hours later, the new number was 505. He’s expecting the wave to hit hard there. Broward is home to Fort Lauderdale (think spring break) and Pompano Beach (think aging retirees). Couple those demographics with a lack of easy testing for the virus, and you’ve got a worrisome situation.
When your heart beats faster than usual, it can mean that you’re coming down with a cold, flu, coronavirus, or other viral infection. That’s the conclusion of recent medical 
On this week’s show, host Joel Goldberg gets an update on the coronavirus pandemic from Senior Correspondent Jon Cohen. In addition, Cohen gives a rundown of 
Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug’s potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.
Boomers Daily 